Umbilical cord blood (CB) represents a main source of circulating endothelial progenitor cells (cEPCs). In view of their clinical use, in either the autologous or allogeneic setting, cEPCs should likely be expanded from CB kept frozen in CB banks. In this study, we compared the expansion, functional features, senescence pattern over culture, and in vivo angiogenic potential of cEPCs isolated from fresh or cryopreserved CB (cryoCB). cEPCs could be isolated in only 59% of cryoCB compared to 94% for fresh CB, while CB units were matched in terms of initial volume, nucleated and CD34 + cell number. Moreover, the number of endothelial colony-forming cells was significantly decreased when using cryoCB. Once cEPCs culture was established, the proliferation, migration, tube formation, and acetylated-LDL uptake potentials were similar in both groups. In addition, cEPCs derived from cryoCB displayed the same senescence status and telomeres length as that of cEPCs derived from fresh CB. Karyotypic aberrations were found in cells obtained from both fresh and cryoCB. In vivo, in a hind limb ischemia murine model, cEPCs from fresh and cryoCB were equally efficient to induce neovascularization. Thus, cEPCs isolated from cryoCB exhibited similar properties to those of fresh CB in vitro and in vivo. However, the low frequency of cEPCs colony formation after cryopreservation shed light on the need for specific freezing conditions adapted to cEPCs in view of their future clinical use.
INTRODUCTION
cularization sites, and proliferation and differentiation into endothelial cells (29, 41) . cEPCs have been identified mainly in the mononu-Until recently, neovascularization or formation of new blood vessels has been thought to result exclusively clear cell fraction of peripheral blood, leukapheresis products, and in umbilical cord blood (1,5). Recently from proliferation and migration of preexisting endothelial cells, a process referred as to angiogenesis (7) . Fur-cEPCs have been extensively studied as biomarkers to assess the risk of cardiovascular disease in human sub-thermore, vascularization, defined as in situ differentiation of vascular endothelial cells from endothelial jects. Indeed, a lower cEPCs count predicts severe impaired functions in several cardiovascular pathologies precursor cells, was thought to occur only in the embryo during vascular development. It is nowadays established such as diabetes (12) , hypercholesterolemia (8) , hypertension (38, 45) , scleroderma (10, 25) , aging (17,45), cig-that circulating bone marrow-derived endothelial progenitor cells (cEPCs) are capable of homing to neovas-arette smoking (23, 32, 45) , and coronary artery disease (46) . Transplantation of cEPCs into ischemic tissues gen type I-coated wells (Becton Dickinson, Le Pont de Claix, France), and maintained in endothelial basal me-thus emerged as a promising approach in the treatment of diseases with blood vessels disorders (6, 22, 28) . dium-2 (EBM2) supplemented with EGM2-MV Single-Quots (Lonza, Ermerainville, France) at 37°C, under 5% In the mouse, cEPCs injection led to improved neovascularization in hind limb ischemia (6, 22, 28) . Ex vivo CO 2 , in a humidified incubator. First media change was performed after 24 h to eliminate nonadherent cells and expanded cEPCs, isolated from peripheral blood mononuclear cells, can also incorporate into the foci of myo-daily for 7 days. Media was then changed every 2 days. The outgrowth of endothelial colony-forming cells cardial neovascularization (11, 26) , and intracoronary infusion of peripheral blood or bone marrow-derived (ECFC), characterized by formation of a cluster of cobblestone-appearing cells, was assessed daily. Colonies progenitors in patients with acute myocardial infarction was associated with significant benefits in postinfarction were enumerated by visual inspection using an inverted microscope (Olympus, Lake Success, NY) under 40× remodeling (13, 30, 31, 34, 36, 37, 42, 43) .
For the two last decades, umbilical cord blood (CB) magnification. To obtain cEPC-derived cells, ECFC were trypsinized, seeded at 10,000 cells/cm 2 , and ex-has served as a source of hematopoietic progenitor cells, which are used for the treatment of various high-risk panded in EGM2-MV media. hematological malignancies in children and adults. CB Flow Cytometry Quantification and Phenotype Analysis is also a treatment of choice in nonmalignant disorders and acquired or inherited bone marrow failure syn-Mononuclear cells were enriched as previously described (3), using a Human RosetteSep Progenitor En-dromes (39). CB banking for allogeneic hematopoietic stem cell transplantation has been established worldwide richment kit (Stem Cell technologies, Canada). Cells were then subjected to triple labeling with anti-CD133-over the past, with cryopreservation methods allowing maintenance of viability over years (15) . phycoerhytrin (PE, Miltenyi Biotec, Paris, France), anti-CD34-fluorescein isothiocyanate (FITC, Becton Although the impact of freezing on hematopoietic stem cells has been extensively studied (4,16,24,33,47), Dickinson), and biotinylated anti-VEGFR-2 (KDR) (Sigma-Aldrich, Saint Quentin Fallavier, France) anti-it has not been clearly determined whether or not these processes maintain other stem and progenitor cells as bodies. Viability was assessed with 7-AAD (Becton Dickinson). Immunophenotyping of cEPC-derived cells viable and functional. This question is of crucial importance because thousands of CB cells are collected, cryo-was assessed by using the following monoclonal antibodies: CD31-FITC, CD144-PE (Becton Dickinson), preserved, and stored in anticipation of their potential therapeutic application in regenerative medicine. As an VEGFR2-APC (APC, R&D Systems, Minneapolis, MN), and von Willebrand Factor (vWF) (Dako, Trappes, example, CB is a main source of cEPCs, which can be ex vivo expanded with a higher frequency and a robust France). For intracellular labeling, cells were permeabilized with phosphate-buffered saline (PBS)/saponin solu-proliferative potential compared to cEPCs from adult peripheral blood (19) . CB thus represents a valuable source tion. Antibodies and matched isotype control were incubated for 30 min at 4°C. Data were acquired and for the production of cEPCs to be used in the treatment of a wide range of cardiovascular diseases. To that end, analyzed on a five-parameter flow cytometer (FACScalibur, Becton Dickinson, San Jose, CA) with CellQuest in both the autologous or allogeneic setting, cEPCs should likely be expanded from cryopreserved CB software (Becton Dickinson). (cryoCB) in CB banks. In this study, we aimed to com-Cell Proliferation Potential pare the expansion potential of cEPCs isolated from fresh or cryoCB, together with their in vitro and in vivo At subconfluence, cells were detached and counted. The number of population doublings (PD) was calcu-functional properties. lated at each passage using the following formula: log 2 MATERIALS AND METHODS (n f /n o ), where n o is the initial and n f the final cell number Isolation and Culture Conditions of CB cEPCs at each passage. The cumulative population doubling was calculated as the sum of all previous PDs. Popula-Human umbilical CB was collected from normal fullterm deliveries after maternal informed consent accord-tion doubling time (PDT) and cumulative population doubling time (CPDL) were calculated using the follow-ing to approved institutional guidelines (Assistance Publique-Hôpitaux de Paris, Paris, France). Cryopre-ing formula: t/PD, where t is the interval of time of culture between each passage. served CB was maintained at a temperature below −150°C at the Saint-Louis Hospital Cord Blood Bank,
In Vitro Angiogenesis Assay Paris, France. Mononuclear cells (MNCs) obtained from fresh or thawed CB were isolated by centrifugation on Capillary tube formation was performed by laying Matrigel (Becton Dickinson) into a 12-well plate. cEPC-Pancoll (Dutscher, Burmath, France), plated onto colla-derived cells were seeded on Matrigel (2 × 10 5 cells/ restriction fragments (TRFs) length was determined by chemiluminescent detection. well) and suspended in EGM2-MV medium for 18 h at 37°C with 5% CO 2 . Capillary tube formation in Matrigel RNA Extraction and Quantitative PCR was observed under an inverted microscope and kinetic of tube formation was assessed by taking pictures every Cells were collected at passages 4, 7, and 8. Total RNA was extracted with RNeasy mini-kit (Qiagen, Hil-2 hours. den, Germany) and cDNA prepared with the cDNA Ar-Wound-Healing Assay chive kit (Applied Biosystems, Foster City, CA). Quantitative PCR (qPCR) was performed with TaqMan Cell migration was analyzed by using the method described by Sato and Rifkin with modifications (40) . One Gene Expression Assays on an ABI7000 (Applied Biosystems) in the presence of 10 ng of RNA. CD146, linear scar was drawn in a confluent cEPC-derived cells monolayer. A set of digital photographs was taken. eNOS, KDR, ephrin-B4, Eph-B2, Alk-1, COUPTFII, and RPLP0 (ribosomal protein, endogenous control) Dishes were then incubated for 18 h in EGM2-MV medium and a second set of photographs was taken.
expressions were assessed (predesigned assays, references respectively: Hs00163543_m1, Hs00174838_m1, Ac-LDL Uptake Hs00819630_m1, Hs00167166_m1, Hs00187950_m1, Hs00174752_m1, Hs00176676_m1, Hs99999902_m1). Incorporation analysis of acetylated low-density lipoprotein 488 (Ac-LDL 488; Invitrogen, Cergy-Pontoise,
The 2-∆∆Ct method was used and results expressed as gene expression fold increase relative to human umbili-France) was performed to assess the incorporation ability of cEPCs. Cells were incubated with 15 mg/ml of cal vein endothelial cells (HUVECs). Ac-LDL 488 in endothelial medium for 4 h at 37°C, Karyotype Analysis washed three times, and mounted with Glycergel mounting medium (Dako). Ac-LDL uptake was observed un-cEPCs at 70% confluence in culture with EBMV2 medium were incubated with colchicine (4 µg/ml, der a fluorescence microscope and analyzed with Metamorph software.
Sigma-Aldrich) for 3 h. The cells were then trypsinized and incubated with hypotonic solution (0.075 M KCl).
TNF-α Activation
Metaphases were fixed with methanol/acetic acid (3:1, v/v). Cytogenetic analysis was performed using R band-Cells were seeded at 2 × 10 4 cells/well and, once at confluence, stimulated with TNF-α (10 ng/ml) for 18 h.
ing procedure. Images were acquired with the MET-AFER system (METAsystems, Germany) on Zeiss mi-After incubation, cells were trypsinized and stained with ICAM-1 and VCAM-1 primary antibodies (R&D Systems) croscope and chromosomes were classified with the IKAROS software (METAsystems, Germany). The re-and goat anti-mouse secondary antibody (Invitrogen). Data were acquired and analyzed on a five-parameter sults were reported according to International System for Human Cytogenetic Nomenclature (ISCN; 2005). A flow cytometer (FACScalibur, Becton Dickinson). minimum of 20 metaphases were screened from each Senescence-Associated (SA)-β-Galactosidase Assay sample. Cells were washed, fixed, and incubated overnight at Hind Limb Ischemia Model 37°C with X-gal chromogenic substrate at pH 6.0 following the manufacturer's instructions. After staining,
In vivo cEPCs angiogenesis potential was assessed in a NOD/SCID mice model of hind limb ischemia. NOD/ cells were analyzed on pictures of five randomly selected fields.
SCID mice were purchased from The Villejuif Animal Experiment Laboratory. All experimental procedures Telomere Length were performed under French authorities' guidelines. Twelve 8-week-old female mice were anesthetized with Genomic DNA was prepared using a "High pure PCR template preparation kit" (Roche Diagnostics, Meylan, a mix of ketamin and xylazine. The left proximal and distal parts of the femoral artery of the left leg were then France). For this purpose, 2 µg DNA was digested at 37°C with restriction enzymes RsaI and HinfI (Roche ligated (6.0 silk suture, Ethicon, Issy-Les-Moulineaux, France) and the part between ligations was excised. Diagnostics). DNA fragments were separated by gel electrophoresis at 130 V on a 1% agarose gel and trans-Seven days after surgery, cEPC-derived cells expanded from fresh or cryoCB were intramuscularly injected in ferred to a nylon membrane. Membranes were washed twice in 2× SSC for 15 min at room temperature and tibialis anterior of the ischemic limb (1 × 10 6 cells per animal). A PBS/albumin injection was used in the con-hybridized with digoxigenin solution and telomeres oligonucleotides for 3 h at 42°C. Membranes were washed trol group. Hind limb blood flow was measured using a scanner-laser Doppler (Laser Doppler Perfusion system, in 1× SSC, 0.1% SDS for 15 min at 50°C. Terminal Perimed Periscan II). Average perfusion of ischemic and means between the two groups, with the associated 95% confidence intervals (CI), and analyzed with a two-way nonischemic limbs was determined before and after ischemia, and 34 days after ischemia. Blood flow-depen-analysis of variance (ANOVA) with p-values adjusted with the Bonferonni method. A value of p < 0.05 was dent changes in laser frequency were imaged using different colored pixels. Images were analyzed to quantify considered as indicating significant difference. blood flow by using a blood perfusion analyze software RESULTS (LPDIwin). Percentage of perfusion was expressed as Isolation, Expansion, and Characterization of cEPCs the ratio of the ischemic to the nonischemic hind limb.
Derived From Fresh and cryoCB Thirty-four days after surgery, animals were sacrificed. Muscles isolated from the ischemic hind limb were fixed cEPCs were quantified as lin − /7AAD − /CD34 + /CD133 + / KDR + -positive cells in the mononuclear fraction of fresh in paraffin and stained with HES (hemalun-eosine-saffron).
(n = 17) and thawed (n = 17) CB. 1A) , while the initial number of nucleated cells was similar in both conditions, as well as the from in vivo experiment were expressed as geometric We first analyzed the ability of CB cEPC-derived cases. Immunohistochemistry experiments in which cEPC-derived cells were labeled with anti-CD31 antibodies confirmed that these tubular vessels like structures were composed of endothelial cells (Fig. 2C, D) . CB volumes initially harvested. Despite that, the mean number of ECFC was dramatically reduced in the Because migration capacity is one of the endothelial cell features, we ran an in vitro wound-healing assay thawed CB group (3.5 ECFC for thawed CB vs. 13.9 ECFC for fresh CB, p = 0.02) ( Fig. 1B) , even if ECFC using cEPC-derived cells expanded from fresh or cry-oCB. In both experiments, the cells were shown to over-morphology was similar (Fig. 1C) . The ECFC outgrowth potential was a mean of 7.6 days (range 5- 14) run the scars and to form a continuous monolayer ( Fig.  2E-H) . The time the cells took to migrate and cover the in the cryoCB group, compared to 10.7 days (range 5-16) for fresh CB (p < 0.05). However, we were able to scar did not differ significantly among the two groups. This wound-healing model is not solely a migration generate ECFC from only 59% of thawed CB whereas 94% of fresh CB efficiently gave rise to ECFC, thus model. It also involves cell proliferation at the wound border. To confirm that cell proliferation did not impact demonstrating that cryopreservation and thawing significantly altered the capacity to generate and expand the results of this assay, cell growth kinetic was evaluated at the time the wound-healing assay was performed. cEPCs.
Because cryopreservation affects, to a great extent, Similar cell population doublings were observed between fresh and cryoCB-derived cells (data not shown). the survival of human cEPCs, we next evaluated whether or not it also modifies other biological parame-
The ability to incorporate Ac-LDL has been described as another characteristic of endothelial cells. cEPC-derived ters such as immunophenotype, proliferation potential, and specific endothelial gene expression, and compared cells expanded from fresh or cryoCB were incubated in the presence of Ac-LDL during 4 h. As shown in Figure  them to fresh cEPCs taken as a reference. In both cases, 2I and J, the Ac-LDL uptake was demonstrated to be also similar in both conditions: 96.1 ± 1.2% and 96 ± 2% at passage 2 and 10, respectively, for fresh CB, and efficient in both cases and similar to that observed in HUVECs (not shown).
95.8 ± 1.4% and 96.5 ± 1.2% at similar passages for cryoCB ( Fig. 4B ). Telomere length was measured from Phenotypically, and under standard culture conditions, cEPC-derived cells express low levels of ICAM-passage 2 to passage 14, on cells expanded from cryopreserved or fresh CB. While a slight and expected de-1 and do not express VCAM-1 molecule. However, these levels of expression are increased in response to crease of telomere length was observed at the highest passages ( Fig. 4C) , no significant differences could be TNF-α stimulation. We incubated cEPC-derived cells in the presence of 10 ng/ml TNF-α and analyzed the ex-evidenced between the two groups, thus suggesting that cryopreservation and thawing did not influence cell pression of these two adhesion molecules at the membrane surface. After stimulation, an upregulation of both growth and survival, once the cells are obtained. ICAM-1 and VCAM-1 was observed, with greatest ef-Karyotype Analysis of CB cEPC-Derived Cells fects seen with VCAM-1 (Fig. 3) . The expression fold induction was similar between cEPC-derived cells iso-Karyotype analysis was performed on six samples of CB cEPC-derived cells (fresh CB, n = 3; cryoCB, n = lated from fresh or cryoCB, with a median of induction of 3.2 and 3.9 for ICAM-1, respectively, and of 24.6
3). As shown in Table 2 , tetraploid metaphases were detected in three samples (sample 1, fresh CB; samples and 17.2 for VCAM-1, respectively.
Lastly, we determined if some differences existed be-2 and 3, cryoCB), and a trisomy of chromosome 11 in sample 3 (cryoCB). In the three remaining samples, a tween cells grown from fresh or cryoCB regarding senescence and telomere length. cEPC-derived cells were normal karyotype was found. harvested at various culture times and stained with SA-In Vivo Hind Limb Ischemia β-galactosidase, a marker of cell senescence. Whatever the number of cell passages considered (early or late
In vivo neovascularization studies were performed in the NOD/SCID hind limb ischemia model. cEPC-derived passages, i.e., passage 2 or 10), no differences were detected between cells grown from fresh or cryoCB in this cells isolated from fresh or cryoCB (1 × 10 6 per mouse), or placebo (PBS/albumin buffer) were intramuscularly assay (Fig. 4A) . The cell viability, tested in parallel, was given via tibialis injection 7 days after femoral artery limb was completely restored at day 34 for mice receiving cEPC-derived cells compared to the levels measured ligation. Laser Doppler blood flow measurements were taken from both the injured and uninjured legs of all before femoral artery ligation (Fig. 5B) . In contrast, perfusion ratios in the control remained low at day 34 animals. As shown in Figure 5A , blood perfusion was dramatically decreased at day 1 in all groups, thus trig-(61%) compared with 98.3% and 103.6% in the groups that received cEPC-derived cells from fresh or cryoCB, gering ischemia of the operated legs. At day 34, higher perfusion ratios were noted in mice injected with cEPC-respectively (p < 0.05 in both cases compared to control). derived cells from either fresh or cryoCB compared to mice receiving placebo treatment. HES coloration showed DISCUSSION necrotic areas in control PBS-treated mice whereas hind limb muscles exhibited a normal muscular fiber organi-Endothelial progenitor cells derived from frozen CB units holds promise as cellular therapy or tissue engi-zation in the animals transplanted with cEPC-derived cells (Fig. 5A) . The percentage of perfusion of ischemic neering for numerous human vascular diseases (20,35). For years it has been demonstrated that CB represents a thawing process of the whole CB led to an "enrichment" of the cEPCs fraction, mostly by inducing cell death of useful alternate source of cEPCs compared to peripheral blood. A high number of cEPCs could actually be iso-the more mature mononuclear cells and red cell lysis. Indeed, it has already been demonstrated that cEPCs lated from CB, with increased proliferative potential compared to their adult counterpart (18, 19) and better in could be isolated and differentiated into endothelial cells from frozen umbilical CB mononuclear cells (21) . In vivo potential to form vessels (2). Given the important cell number required for therapeutic approaches, in vitro that case, mononuclear cells were preliminarily isolated from CB and stored at −196°C before inducing cEPCs. expansion is a prerequisite for cEPC-derived cell transplantation. To that end, and both in the autologous or However, even if the number of cEPCs was shown to be higher in thawed CB, the fact that the number of allogeneic setting, cEPCs will be expanded from cryoCB.
Worldwide, at least in public CB banks, the CB cryo-ECFCs was reduced tends to demonstrate that cEPCs were less functional than that obtained from fresh CB. preservation process aims at ensuring long-term storage of hematopoietic stem cells, mainly with the view of Once ECFCs could be obtained from cryoCB, the growth kinetics and proliferation potential of cEPCs and allogeneic transplant for hematological disorders. However, it has not been clearly established whether these cEPC-derived cells were similar to that of cells expanded from fresh CB. At this stage, CB thawing did conditions allow isolating and expanding other stem or progenitor cell populations, or if their functional capaci-not seem to have any deleterious effect because no significant alteration of in vitro cEPCs properties was ob-ties are preserved after the thawing procedure. By using a CD34 + magnetic cell sorting for EPCs isolation and served. Thus, cEPCs and cEPC-derived cells from fresh or cryoCB expressed the same membrane antigen that culture, Lu et al. (27) showed that they were unable to generate endothelial-like cells from cryopreserved CB.
features these two cell types. The qPCR results we presented in Table 1 showed that cEPC-derived cells ex-This was found to be mainly related to increased apoptosis of CD34 + cells after thawing. pressed both arterial and venous genes. Indeed, these cells expressed COUPTFII and ephrin-B4 venous genes, In our study, we compare isolation, expansion, and in vitro and in vivo functional characteristics of cEPC-but also expressed arterial genes such as Alk-1. cEPCderived cells thus displayed an hybrid arterial-venous derived from fresh or cryoCB. Consistent with previous reports (2, 9, 14, 18, 21) , we succeed in quantifying, isolat-phenotype.
In vitro functional properties, such as tube formation, ing, and expanding cEPCs from almost all tested fresh CB. Conversely, cEPCs could be obtained in less than migration, and Ac-LDL uptake potentials were shown to be similar in the two groups. ICAM and VCAM mole-60% of cryoCB, while these were of an initial volume of more than 70 ml and thawed in the same conditions cules expression before and after stimulation with TNFα revealed no difference between cells expanded from as those used in the allogeneic transplantation setting. Moreover, the number of ECFCs obtained after CB fresh or cryoCB, nor with expression of these molecules on HUVEC. Taken together, these in vitro results dem-thawing was significantly reduced compared to that of fresh CB, thus demonstrating that, even when cryopre-onstrated that cEPCs and cEPC-derived cells from human fresh or cryoCB shared similar functional proper-served with a standardized and validated procedure, thawed CB does not allowed efficiently obtaining ties. However, we also showed that, even using CB of high initial volume and cell number, the yield of cEPC-cEPCs. These results were furthermore obtained where cEPCs count was significantly higher after CB thawing.
derived colonies was relatively low after cryopreservation and thawing. We thought these observations to be One could hypothesize that cryopreservation and of interest in the setting of storing CB for future stem cess by laser Doppler and showed muscular healing in animals treated with cEPC-derived cells. In this vascular cell-based therapy (44). Furthermore, these data highlight the decision that has to be made regarding the stor-injury model, we thus demonstrated that cEPC-derived cells obtained after CB thawing have equivalent efficacy age of poor-quality or low-yield cord collections, especially in the autologous setting for which the criteria of in revascularization than cells from fresh CB. In this study, we showed that cEPCs isolated from CB quality and storage are still to date far from those internationally required for allogeneic CB banking. In cryoCB exhibited similar in vitro and in vivo functional properties as those expanded from fresh CB. However, these conditions, it is very likely that the yield of cEPCderived endothelial cells will be very poor. Whether the the relatively low frequency with which we successfully generated cEPCs after thawing has to be taken into con-frequency of cEPCs in frozen/thawed CB is representative of other stem cells has to be established. Because sideration in view of their future clinical use. Actually, if cEPC-derived cells' therapeutic effect in the hind limb cEPC-derived colonies are relatively easy to obtain, this test may represent a useful quality control assay for CB ischemia mice model gave similar results with fresh and cryoCB, we demonstrated that the number of ECFCs ob-banks.
Recently, the numerous advantages of CB over pe-tained after thawing was significantly reduced compared to that of fresh CB. As a matter of fact, the expansion ripheral blood regarding cEPCs and their potential applications have been tempered by the observations made process to be done for obtaining a sufficient cell number after CB thawing will be prolonged, with the risk, for by Corselli et al. reporting chromosomal abnormalities in CB cEPC-derived cells (9) . Even if cEPCs functional example, of promoting chromosomal abnormalities. Improvements of specific freezing conditions are thus man-features were not altered by these abnormalities, and if none of the treated animals developed tumors, these data datory in order to optimize cEPCs recovery after CB thawing. However, it must not be forgotten that, to date, should be taken into consideration at least in the setting of future clinical application. In our hands, some cEPC-the vast majority of CB units are used in the setting of hematological diseases, and that thawing allows obtain-derived cells also harbored cytogenetic abnormalities; these data were obtained for cryoCB as well as for fresh ing high hematopoietic stem cells recovery. Because these conditions could likely not be modified based ones, thus suggesting that the cryopreservation and thawing process likely does not increase the incidence upon cEPCs, an option might be to freeze cEPC-derived cells, beforehand expanded from part or whole fresh CB. of cytogenetic alterations. At the time the animals were sacrificed, we did not evidence any tumor formation, On a clinical point of view, this strategy likely will not be reasonable for treating genetic diseases in an autolo-similar to that was reported by Corselli et al. (9) . Lastly, we addressed the question of whether or not cryopreser-gous setting because CB cEPC-derived cells could harbor genetic abnormalities. However, developing alloge-vation and thawing modified cell senescence and telomere length, two points that should be of importance if neic CB cEPC-derived cell banks could be of use for proposing new therapeutic approaches for patients with long-term expansion is required for therapeutic approaches. It is important to note that, despite the difficul-ischemic injury. ties to generate cEPCs from some cryoCB, cell senes-ACKNOWLEDGMENT: This work was supported by a grant cence assessed by SA-β-galactosidase staining was from the Agence Nationale de la Recherche (project "Euroequivalent to that of cells isolated from fresh CB. Telocord Lab" No. ANR-07-RIB-005-02). mere length, determined at different culture time points, was also shown to be equivalent in the two conditions, REFERENCES thus demonstrating that cryopreservation does not led to
